Philips Respironics will lay off 14 workers at a Westmoreland County facility after it eliminated a shift.

The company filed a Worker Adjustment and Retraining Notification Act “WARN” notice announcing the layoffs at its facility at 174 Tech Center Drive in Mount Pleasant.

“It is anticipated that these will be permanent terminations and that employee separations will commence on May 23, 2025,” the company wrote in the WARN notice in late March. “The affected employees have no bumping rights, nor are they represented by a union.”

The positions being eliminated include warehouse operators, managers and coordinators, and an analyst.

Advertise with us

A company official said Wednesday that the decision to lay off the employees was “difficult but necessary.”

“We’re implementing this action in line with all local requirements and are supporting the impacted employees,” said Mario Fante, Philips’ global external relations director, in an email to the Post-Gazette. “Philips Respironics continues to have a substantive footprint in Western Pennsylvania, which remains a strong development hub for the Sleep & Respiratory Care business.”

The layoffs follow the company’s decision last year to move its manufacturing operations to Thailand and end its reign in the Pittsburgh area as one of the nation's leading makers of breathing machines, which the Post-Gazette reported in October. The move was expected to slash hundreds of local jobs that had been a part of the regional economy for decades.

That decision came years after a massive recall in June 2021. Philips discovered that a foam in its once popular sleep apnea machines and ventilators was breaking down and emitting chemicals like formaldehyde at levels that were far beyond thresholds of safety. It received complaints about the foam crumbling into black particles inside the air chambers and, in some cases, leaving patients sick and showing up in hospital emergency rooms.

After an investigation, federal regulators struck a consent decree with Philips calling for the company to submit to a host of safety reforms, including regular inspections of its facilities and a halt to the selling of its breathing machines in the U.S. until certain conditions were met.

It was unclear Wednesday whether the company planned additional exits from the region.